Role of polymerase chain reaction-based viral detection in pterygia.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
02 2023
Historique:
entrez: 2 2 2023
pubmed: 3 2 2023
medline: 4 2 2023
Statut: ppublish

Résumé

Pterygium is a fibrovascular disease that originates in the conjunctiva and commonly spreads to the corneal surface, thereby posing a threat to eyesight. Despite intensive research, the pathophysiology of this disease remains unclear. Recent research suggests that oncogenic viruses, such as human papillomavirus (HPV), cytomegalovirus, and Epstein-Barr virus (EBV), may play a role in pterygia development. Although there are questions concerning the function of oncogenic viruses in pterygium pathogenesis, existing research shows a lack of consensus on the subject, demonstrating the heterogeneity of pterygium pathophysiology. Therefore, we aimed to simultaneously detect the three common viral pathogens that have been reported in pterygium tissue obtained after excision. Thirty-five tissue specimens of pterygium from patients undergoing pterygium surgery (as cases) were analyzed for evidence of viral infection with multiplex polymerase chain reaction (PCR), and virus-specific real-time quantitative PCR was used for the samples that were detected positive by multiplex PCR. Of the 35 patients, one sample was positive for EBV and two samples were positive for HPV. Further PCR-based DNA sequencing of the HPV PCR-positive product showed identity with HPV-16. Real-time quantitative PCR on samples that showed EBV or HPV positivity did not yield any detectable copy number. Our study results confirmed that PCR positivity could be due to transient flora, but it was not quantitatively significant to conclude as the causative factor of pterygium pathogenesis. However, additional studies with larger sample populations are warranted to fully determine the role of the virus in pterygium.

Identifiants

pubmed: 36727340
pii: IndianJOphthalmol_2023_71_2_458_368941
doi: 10.4103/ijo.IJO_1632_22
pmc: PMC10228951
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

458-463

Déclaration de conflit d'intérêts

None

Références

Invest Ophthalmol Vis Sci. 2000 Mar;41(3):671-9
pubmed: 10711680
Br J Ophthalmol. 2001 Jul;85(7):782-4
pubmed: 11423447
Genet Mol Res. 2008;7(4):1251-8
pubmed: 19065760
Ther Adv Ophthalmol. 2021 May 31;13:25158414211020152
pubmed: 34104871
Br J Ophthalmol. 2003 Aug;87(8):1046-8
pubmed: 12881355
Arch Ophthalmol. 1999 Dec;117(12):1593-9
pubmed: 10604662
Br J Ophthalmol. 2003 Jul;87(7):864-6
pubmed: 12812887
Br J Ophthalmol. 2007 Aug;91(8):1016-8
pubmed: 17179167
Arq Bras Oftalmol. 2006 Jul-Aug;69(4):519-21
pubmed: 17119724
Int J Mol Med. 2009 Apr;23(4):439-47
pubmed: 19288018
Acta Ophthalmol. 2016 May;94(3):e195-7
pubmed: 25864511
Clin Ther. 2015 Oct 1;37(10):2347-51
pubmed: 26409291
Acta Ophthalmol Scand. 2007 Aug;85(5):551-6
pubmed: 17362365
BMC Ophthalmol. 2017 Nov 25;17(1):211
pubmed: 29178848
Int J Mol Med. 2013 Sep;32(3):539-43
pubmed: 23856952
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3430-7
pubmed: 12407153
Curr Eye Res. 2009 Aug;34(8):666-71
pubmed: 19899994
Acta Ophthalmol. 2014 Nov;92(7):e569-79
pubmed: 25043991
Ocul Surf. 2008 Jan;6(1):24-43
pubmed: 18264653
Acta Ophthalmol. 2009 Nov;87(8):890-5
pubmed: 19302081
Br J Cancer. 2004 May 4;90(9):1777-9
pubmed: 15150602
BMJ Open. 2013 Nov 19;3(11):e003787
pubmed: 24253031
Int J Oncol. 1994 Oct;5(4):749-52
pubmed: 21559637
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3462-7
pubmed: 20207965
Eye (Lond). 2008 Nov;22(11):1442-5
pubmed: 18535585
Exp Eye Res. 2016 Jan;142:32-9
pubmed: 26675401
Cent Afr J Med. 1994 Jan;40(1):24-6
pubmed: 8082148
Cornea. 2008 Apr;27(3):311-3
pubmed: 18362659
Cornea. 2010 Feb;29(2):123-7
pubmed: 19907287
Cornea. 2001 Mar;20(2):164-7
pubmed: 11248821
Eur J Ophthalmol. 2009 Mar-Apr;19(2):175-9
pubmed: 19253231

Auteurs

Janani Madhuravasal Krishnan (JM)

Sankara Nethralaya Referral Laboratory, Medical Research Foundation, Chennai, Tamil Nadu, India.

Rama Rajagopal (R)

Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.

Dhanurekha Lakshmipathy (D)

Sankara Nethralaya Referral Laboratory, Medical Research Foundation, Chennai, Tamil Nadu, India.

Shweta Agarwal (S)

Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.

A R Anand (AR)

L&T Microbiology Research Centre, Vision Research Foundation, Chennai, Tamil Nadu, India.

Lily Therese (L)

L&T Microbiology Research Centre, Vision Research Foundation, Chennai, Tamil Nadu, India.

Aishwarya Thangam (A)

Sankara Nethralaya Referral Laboratory, Medical Research Foundation, Chennai, Tamil Nadu, India.

Hajib Narahari Rao Madhavan (HNR)

Sankara Nethralaya Referral Laboratory, Medical Research Foundation, Chennai, Tamil Nadu, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH